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Conclusions: We have established a whole tissue model for os-
teoarthritis comprising both cartilage and bone, which is highly
responsive to both catabolic and anabolic stimulation. This model
responded both anabolic and catabolic to PTH treatment, demon-
strating the importance of cell-cell communication. The dual effect
on cartilage may be divided in direct and indirect effects from PTH
on bone and cartilage, which had not been possible to detect in a
single-tissue model system. This model may be useful for testing
potential disease-modifying osteoarthritis drugs (DMOADs) inter-
fering with more than one aspect of the pathological situation.
Furthermore, it presents a unique opportunity for investigating the
role of osteoclast-, osteoblast- and chondrocyte-interactions in the
pathogenesis of OA and other joint degenerative diseases.
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Purpose: To determine whether the H4 receptor is pharmacolog-
ically expressed in human OA and RA tissues, and the different
cell types that express this receptor.
Methods: Human synovial tissues from OA and RA tissues were
collected with the consent from patients undergoing total knee
replacement. These tissues were investigated using RT-PCR, im-
munohistochemistry and by competitive radiolabled antagonist
binding assays. The expression of H4R RNA and protein were
investigated using RT-PCR and immunohistochemical methods
with human H4R antibodies. Synovial membranes were evaluated
histologicaly following Hematoxyline Eosine staining. To determine
the phenotype of the cells expressing H4R, mast cells were re-
vealed using anti tryptase and c-kit antibodies. Dentritic cells,
macrophage and endothelial cells were revealed using S100,
CD68 and the Von Willebrand factor respectively. CD4 was used
as a marker for mature helper T cells, and CD8 as a marker for
mature Cytotoxic T cells. To ascertain whether the H4 receptor is
pharmacologically expressed, human OA synoviocytes from 5 pa-
tients were evaluated in competitive radiolabled antagonist binding
assays. The effect of Thioperamide on metalloproteinases was
studied zymography.
Results: The H4 receptor was detected at RNA and protein levels
in both OA and RA synovial tissues, with a signiﬁcantly greater
number of cells staining positive in inﬂammatory RA tissues. In
synovial membranes from patients with RA, H4 receptor was de-
tected in mast and dentritic cells as well as in the macrophage-like
type B synoviocytes inﬁltrating within the vascular wall, in the
diffuse cellular inﬁltrate and in the superﬁcial lining cell layer and
in the pannus. When vessels from rheumatoid synovial mem-
branes or OA showed features of vasculitis, a positive signal for
H4 receptor was detected within the media and adventitia of the
vascular wall but not in the internal tunic endothelial cells (in-
tima, which stains positive for the von Willebrand factor). In newly
dissociated and cultured human OA synoviocytes, speciﬁc [3H] ra-
diolabeled antagonist binding was displaced by both Thioperamide
and a selective H4 receptor antagonist indicating expression of
pharmacologically active H4R in these diseased tissues. The zy-
mographies revealed that MMP-9 activity is upregulated by IL-1b
and this effect is greatly diminished by Thioperamide.
Conclusions: This study shows the in situ localization of H4R in
human OA and RA tissues in both inﬁltrating immune cells and
synoviocytes associated with disease pathogenesis. We provide
also ﬁrst pharmacological evidence of H4R expression by radio-
labeled binding. Hence, H4R may be an attractive target in the
development of new approaches for therapeutic treatment of OA
and RA and possibly other diseases where histamine plays a cru-
cial event in mediating leukocyte trafﬁcking and tissue degradation.
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Purpose: Anteromedial gonarthrosis (AMG) is a distinct pheno-
type of osteoarthritis (OA), with a speciﬁc pattern of disease.
There is full thickness cartilage loss anteromedially, progressing
to an area of damaged cartilage, and then to an area of macro-
scopically and histologically normal cartilage posteriorly. It can be
considered to be a spatial model of OA progression
Apoptosis, or chondrocyte cell death, has been shown to be a fea-
ture of OA cartilage, however the triggers are poorly understood;
similarly, reactive oxygen species (ROS) have been implicated in
OA. They have never been studied in a replicable topographical
model of OA.
This study characterises the regional levels of cell death and
implicated ROS in AMG using a number of immunohistochemical
studies.
Methods: Ten tibial resection specimens were obtained from
patients undergoing unicompartmental knee arthroplasty. Eight
above knee amputations (from patients with peripheral vascular
disease) were used as age matched controls.
Cross sections taken through all regions were parafﬁn embed-
ded. Routine histology was performed and immunohistochemical
studies were conducted for Terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL), Active Caspase 3, Cytochrome
C, Active Bax, Bim, 3-Nitrotyrosine and Forkhead box O3A (FOXO
3A).
Results: Cell death, as detected by TUNEL appeared predomi-
nantly in the surface layer of chondrocytes of damaged cartilage
(p<0.001). Median values were 23% in superﬁcial cartilage (range
0 - 51) compared to 0% in deeper cartilage (range 0 - 15). There
was a signiﬁcant difference in TUNEL staining between regions
(p=0.001). This ranged from 26% (most damaged) to 4% (un-
damaged). There was a good correlation with degree of cartilage
damage (ρ=0.66, p<0.001) as deﬁned by histological grade and
TUNELwas signiﬁcantly higher (p<0.001) in AMG compared to the
control samples which showed an average of 2% TUNEL overall.
Upstream markers of apoptosis (Active Caspase 3, Cytochrome
C, Active Bax), assessed qualitatively, were present in a similar
distribution to that of TUNEL staining.
3-Nitrotyrosine was also shown to be a predominantly surface phe-
nomenon. There was a signiﬁcant difference (p<0.001) between
regions, ranging from 58% (most damaged) to 10% (undam-
aged). Again, this was signiﬁcantly higher that the control samples
(p<0.001). In line with indicators of ROS mediated damage, Bim
and FOXO3A were also detected.
Conclusions: The mechanism of apoptosis in OA cartilage has
not been studied in depth, and understanding the biochemical
and molecular responses of ‘stressed’ chondrocytes may provide
invaluable information about the speciﬁc causes of cell death. Such
cellular responses may provide targets for disease modiﬁcation,
thus delaying or preventing the need for joint arthroplasty.
We conclude that AMG is a phenotype demonstrating cartilage
at progressive stages of disease. Apoptosis involves the intrinsic
mitochondrial pathway and ROS appear to be implicated. Further
work is needed to provide evidence of what lies further upstream
of markers demonstrated in this study.
